Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Population-based prevalence of fetal alcohol spectrum disorder in Canada.

Popova S, Lange S, Poznyak V, Chudley AE, Shield KD, Reynolds JN, Murray M, Rehm J.

BMC Public Health. 2019 Jun 28;19(1):845. doi: 10.1186/s12889-019-7213-3.

2.

Alcohol and the global burden of disease.

Shield KD, Rehm J.

Lancet. 2019 Jun 15;393(10189):2390. doi: 10.1016/S0140-6736(19)30726-3. No abstract available.

PMID:
31204673
3.

The global proportion and volume of unrecorded alcohol in 2015.

Probst C, Fleischmann A, Gmel G, Poznyak V, Rekve D, Riley L, Rylett M, Shield KD, Rehm J.

J Glob Health. 2019 Jun;9(1):010421. doi: 10.7189/jogh.09.010421.

4.

Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study.

Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J.

Lancet. 2019 Jun 22;393(10190):2493-2502. doi: 10.1016/S0140-6736(18)32744-2. Epub 2019 May 7.

PMID:
31076174
5.

Trends in substance use and in the attributable burden of disease and mortality in the WHO European Region, 2010-16.

Rehm J, Manthey J, Shield KD, Ferreira-Borges C.

Eur J Public Health. 2019 Apr 22. pii: ckz064. doi: 10.1093/eurpub/ckz064. [Epub ahead of print]

PMID:
31008515
6.

Does Alcohol Use Affect Cancer Risk?

Rehm J, Soerjomataram I, Ferreira-Borges C, Shield KD.

Curr Nutr Rep. 2019 Mar 20. doi: 10.1007/s13668-019-0267-0. [Epub ahead of print] Review.

PMID:
30895470
7.

Quantifying harms to others due to alcohol consumption in Germany: a register-based study.

Kraus L, Seitz NN, Shield KD, Gmel G, Rehm J.

BMC Med. 2019 Mar 19;17(1):59. doi: 10.1186/s12916-019-1290-0.

8.

Proportion of cancers attributable to major lifestyle and environmental risk factors in the Eastern Mediterranean region.

Kulhánová I, Znaor A, Shield KD, Arnold M, Vignat J, Charafeddine M, Fadhil I, Fouad H, Al-Omari A, Al-Zahrani AS, El-Basmy A, Shamseddine A, Bray F, Soerjomataram I.

Int J Cancer. 2019 Mar 18. doi: 10.1002/ijc.32284. [Epub ahead of print]

PMID:
30882889
9.

Commentary on Costanzo et al. (2019): The need for secondary analyses of prospective cohort studies-creating a better understanding of alcohol consumption and hospitalization.

Shield KD, Rehm J.

Addiction. 2019 Apr;114(4):651-652. doi: 10.1111/add.14557. Epub 2019 Feb 13. No abstract available.

PMID:
30761645
10.

A "buck a beer," but at what cost to public health?

Shield KD, Probst C, Rehm J.

Can J Public Health. 2019 Aug;110(4):512-515. doi: 10.17269/s41997-019-00184-6. Epub 2019 Feb 8.

PMID:
30737723
11.

Global Burden of Disease and the Impact of Mental and Addictive Disorders.

Rehm J, Shield KD.

Curr Psychiatry Rep. 2019 Feb 7;21(2):10. doi: 10.1007/s11920-019-0997-0. Review.

PMID:
30729322
12.

Alcohol use and dementia: a systematic scoping review.

Rehm J, Hasan OSM, Black SE, Shield KD, Schwarzinger M.

Alzheimers Res Ther. 2019 Jan 5;11(1):1. doi: 10.1186/s13195-018-0453-0. Review.

13.

The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015.

Marant-Micallef C, Shield KD, Vignat J, Cléro E, Kesminiene A, Hill C, Rogel A, Vacquier B, Bray F, Laurier D, Soerjomataram I.

Int J Cancer. 2019 Jun 15;144(12):2954-2963. doi: 10.1002/ijc.32048. Epub 2019 Jan 15.

PMID:
30537057
14.

New cancer cases attributable to diet among adults aged 30-84 years in France in 2015.

Shield KD, Freisling H, Boutron-Ruault MC, Touvier M, Marant Micallef C, Jenab M, Deschamps V, Hill C, Ferrari P, Margaritis I, Bray F, Soerjomataram I.

Br J Nutr. 2018 Nov;120(10):1171-1180. doi: 10.1017/S0007114518002544.

PMID:
30401003
15.

Substance use and the objectives of current global health frameworks: measurement matters.

Shield KD, Rehm J.

Addiction. 2018 Oct 29. doi: 10.1111/add.14485. [Epub ahead of print] No abstract available.

PMID:
30370561
16.

Cancers in France in 2015 attributable to occupational exposures.

Marant Micallef C, Shield KD, Vignat J, Baldi I, Charbotel B, Fervers B, Gilg Soit Ilg A, Guénel P, Olsson A, Rushton L, Hutchings SJ, Cléro E, Laurier D, Scanff P, Bray F, Straif K, Soerjomataram I.

Int J Hyg Environ Health. 2019 Jan;222(1):22-29. doi: 10.1016/j.ijheh.2018.07.015. Epub 2018 Aug 30.

PMID:
30174219
17.

Alcohol dependence and very high risk level of alcohol consumption: a life-threatening and debilitating disease.

Rehm J, Guiraud J, Poulnais R, Shield KD.

Addict Biol. 2018 Jul;23(4):961-968. doi: 10.1111/adb.12646.

PMID:
30043407
18.

Occupational exposures and cancer: a review of agents and relative risk estimates.

Marant Micallef C, Shield KD, Baldi I, Charbotel B, Fervers B, Gilg Soit Ilg A, Guénel P, Olsson A, Rushton L, Hutchings SJ, Straif K, Soerjomataram I.

Occup Environ Med. 2018 Aug;75(8):604-614. doi: 10.1136/oemed-2017-104858. Epub 2018 May 7.

PMID:
29735747
19.

The impact of historical breastfeeding practices on the incidence of cancer in France in 2015.

Shield KD, Dossus L, Fournier A, Marant Micallef C, Rinaldi S, Rogel A, Heard I, Pilleron S, Bray F, Soerjomataram I.

Cancer Causes Control. 2018 Mar;29(3):325-332. doi: 10.1007/s10552-018-1015-2. Epub 2018 Feb 20.

PMID:
29464426
20.

Alcohol, tobacco and health care costs: a population-wide cohort study (n = 606 947 patients) of current drinkers based on medical and administrative health records from Catalonia.

Miquel L, Rehm J, Shield KD, Vela E, Bustins M, Segura L, Colom J, Anderson P, Gual A.

Eur J Public Health. 2018 Aug 1;28(4):674-680. doi: 10.1093/eurpub/ckx236.

PMID:
29325000
21.

New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.

Shield KD, Marant Micallef C, de Martel C, Heard I, Megraud F, Plummer M, Vignat J, Bray F, Soerjomataram I.

Eur J Epidemiol. 2018 Mar;33(3):263-274. doi: 10.1007/s10654-017-0334-z. Epub 2017 Dec 6.

PMID:
29214413
22.

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.

Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C, Burton R, Cardoso M, Colom J, Duprez D, Gmel G, Gual A, Kraus L, Kreutz R, Liira H, Manthey J, Møller L, Okruhlica Ľ, Roerecke M, Scafato E, Schulte B, Segura-Garcia L, Shield KD, Sierra C, Vyshinskiy K, Wojnar M, Zarco J.

BMC Med. 2017 Sep 28;15(1):173. doi: 10.1186/s12916-017-0934-1.

23.

Risk, individual perception of risk and population health.

Shield KD, Gmel G, Mäkelä P, Probst C, Room R, Gmel G, Rehm J.

Addiction. 2017 Dec;112(12):2272-2273. doi: 10.1111/add.14011. Epub 2017 Sep 25. No abstract available.

PMID:
28948666
24.

New cancer cases in France in 2015 attributable to different levels of alcohol consumption.

Shield KD, Marant Micallef C, Hill C, Touvier M, Arwidson P, Bonaldi C, Ferrari P, Bray F, Soerjomataram I.

Addiction. 2018 Feb;113(2):247-256. doi: 10.1111/add.14009. Epub 2017 Sep 29.

PMID:
28833736
25.

Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease.

Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, Lönnroth K, Rehm J.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700216. doi: 10.1183/13993003.00216-2017. Print 2017 Jul.

26.

The contribution of unrecorded alcohol to health harm.

Rehm J, Gmel G Sr, Hasan OSM, Imtiaz S, Popova S, Probst C, Roerecke M, Room R, Samokhvalov AV, Shield KD, Shuper PA.

Addiction. 2017 Sep;112(9):1687-1688. doi: 10.1111/add.13865. Epub 2017 Jun 20. No abstract available.

PMID:
28635161
27.

Life-time risk of mortality due to different levels of alcohol consumption in seven European countries: implications for low-risk drinking guidelines.

Shield KD, Gmel G, Gmel G, Mäkelä P, Probst C, Room R, Rehm J.

Addiction. 2017 Sep;112(9):1535-1544. doi: 10.1111/add.13827. Epub 2017 Apr 26.

PMID:
28318072
28.

The relationship between different dimensions of alcohol use and the burden of disease-an update.

Rehm J, Gmel GE Sr, Gmel G, Hasan OSM, Imtiaz S, Popova S, Probst C, Roerecke M, Room R, Samokhvalov AV, Shield KD, Shuper PA.

Addiction. 2017 Jun;112(6):968-1001. doi: 10.1111/add.13757. Epub 2017 Feb 20. Review.

29.

Does alcohol use have a causal effect on HIV incidence and disease progression? A review of the literature and a modeling strategy for quantifying the effect.

Rehm J, Probst C, Shield KD, Shuper PA.

Popul Health Metr. 2017 Feb 10;15(1):4. doi: 10.1186/s12963-017-0121-9. Review.

30.

The association between taxation increases and changes in alcohol consumption and traffic fatalities in Thailand.

Sornpaisarn B, Shield KD, Cohen JE, Schwartz R, Rehm J.

J Public Health (Oxf). 2016 Dec 2;38(4):e480-e488. doi: 10.1093/pubmed/fdv163. No abstract available.

PMID:
28158682
31.

The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012.

Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, Soerjomataram I.

CA Cancer J Clin. 2017 Jan;67(1):51-64. doi: 10.3322/caac.21384. Epub 2016 Oct 19.

32.

The effects of alcohol-related harms to others on self-perceived mental well-being in a Canadian sample.

Lewis-Laietmark C, Wettlaufer A, Shield KD, Giesbrecht N, April N, Asbridge M, Dell C, Rehm J, Stockwell T.

Int J Public Health. 2017 Jul;62(6):669-678. doi: 10.1007/s00038-016-0924-7. Epub 2016 Nov 29.

PMID:
27900393
33.

Disability and Functioning of Patients Who Use Psychiatric Hospital Emergency Services.

Shield KD, Kurdyak P, Shuper PA, Rehm J.

J Clin Psychiatry. 2016 Oct;77(10):e1278-e1286. doi: 10.4088/JCP.15m10082.

PMID:
27631147
34.

Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.

Shield KD, Parkin DM, Whiteman DC, Rehm J, Viallon V, Micallef CM, Vineis P, Rushton L, Bray F, Soerjomataram I.

Curr Epidemiol Rep. 2016 Sep;3(3):201-211. doi: 10.1007/s40471-016-0085-5. Epub 2016 Aug 1.

35.

Alcohol consumption and burden of disease in the Americas in 2012: implications for alcohol policy.

Shield KD, Monteiro M, Roerecke M, Smith B, Rehm J.

Rev Panam Salud Publica. 2015 Dec;38(6):442-9.

PMID:
27440091
36.

On the relationship between epidemiology and policy.

Imtiaz S, Shield KD, Roerecke M, Cheng J, Popova S, Fischer B, Rehm J.

Addiction. 2016 Sep;111(9):1687-8. doi: 10.1111/add.13420. Epub 2016 May 26. No abstract available.

PMID:
27228134
37.

Alcohol Use and Breast Cancer: A Critical Review.

Shield KD, Soerjomataram I, Rehm J.

Alcohol Clin Exp Res. 2016 Jun;40(6):1166-81. doi: 10.1111/acer.13071. Epub 2016 Apr 30. Review.

PMID:
27130687
38.

Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview.

Rehm J, Shield KD, Roerecke M, Gmel G.

BMC Public Health. 2016 Apr 28;16:363. doi: 10.1186/s12889-016-3026-9.

39.

The burden of disease attributable to cannabis use in Canada in 2012.

Imtiaz S, Shield KD, Roerecke M, Cheng J, Popova S, Kurdyak P, Fischer B, Rehm J.

Addiction. 2016 Apr;111(4):653-62. doi: 10.1111/add.13237. Epub 2016 Jan 5.

PMID:
26598973
40.

Alcohol Use Disorders in Primary Health Care: What Do We Know and Where Do We Go?

Rehm J, Anderson P, Manthey J, Shield KD, Struzzo P, Wojnar M, Gual A.

Alcohol Alcohol. 2016 Jul;51(4):422-7. doi: 10.1093/alcalc/agv127. Epub 2015 Nov 15. Review.

PMID:
26574600
41.

Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study.

Kontis V, Mathers CD, Bonita R, Stevens GA, Rehm J, Shield KD, Riley LM, Poznyak V, Jabbour S, Garg RM, Hennis A, Fouad HM, Beaglehole R, Ezzati M.

Lancet Glob Health. 2015 Dec;3(12):e746-57. doi: 10.1016/S2214-109X(15)00179-5. Epub 2015 Oct 20.

42.

Estimates of alcohol-related oesophageal cancer burden in Japan: systematic review and meta-analyses.

Roerecke M, Shield KD, Higuchi S, Yoshimura A, Larsen E, Rehm MX, Rehm J.

Bull World Health Organ. 2015 May 1;93(5):329-338C. doi: 10.2471/BLT.14.142141. Epub 2015 Feb 24. Review.

43.

Can pricing deter adolescents and young adults from starting to drink: An analysis of the effect of alcohol taxation on drinking initiation among Thai adolescents and young adults.

Sornpaisarn B, Shield KD, Cohen JE, Schwartz R, Rehm J.

J Epidemiol Glob Health. 2015 Dec;5(4 Suppl 1):S45-57. doi: 10.1016/j.jegh.2015.05.004. Epub 2015 Jun 13.

44.
45.

Temporal Changes in Alcohol-Related Morbidity and Mortality in Germany.

Kraus L, Pabst A, Piontek D, Gmel G, Shield KD, Frick H, Rehm J.

Eur Addict Res. 2015;21(5):262-72. doi: 10.1159/000381672. Epub 2015 May 5.

PMID:
25967383
46.

Russia-specific relative risks and their effects on the estimated alcohol-attributable burden of disease.

Shield KD, Rehm J.

BMC Public Health. 2015 May 10;15:482. doi: 10.1186/s12889-015-1818-y.

47.

People with alcohol use disorders in specialized care in eight different European countries.

Rehm J, Allamani A, Aubin HJ, Della Vedova R, Elekes Z, Frick U, Jakubczyk A, Kostogianni N, Landsmane I, Manthey J, Miquel L, Paille F, Pieper L, Probst C, Scafuri F, Shield KD, Snikere S, Struzzo P, Trapencieris M, Voller F, Wittchen HU, Gual A, Wojnar M.

Alcohol Alcohol. 2015 May;50(3):310-8. doi: 10.1093/alcalc/agv009. Epub 2015 Feb 25.

48.

Harms of prescription opioid use in the United States.

Imtiaz S, Shield KD, Fischer B, Rehm J.

Subst Abuse Treat Prev Policy. 2014 Oct 27;9:43. doi: 10.1186/1747-597X-9-43.

49.

Prevalence of and potential influencing factors for alcohol dependence in Europe.

Rehm J, Anderson P, Barry J, Dimitrov P, Elekes Z, Feijão F, Frick U, Gual A, Gmel G Jr, Kraus L, Marmet S, Raninen J, Rehm MX, Scafato E, Shield KD, Trapencieris M, Gmel G.

Eur Addict Res. 2015;21(1):6-18. doi: 10.1159/000365284. Epub 2014 Oct 18.

50.

Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study.

Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, Riley LM, Poznyak V, Beaglehole R, Ezzati M.

Lancet. 2014 Aug 2;384(9941):427-37. doi: 10.1016/S0140-6736(14)60616-4. Epub 2014 May 2.

PMID:
24797573

Supplemental Content

Loading ...
Support Center